Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Clement Goehrs is a medical doctor and entrepreneur, best known as the co-founder and CEO of Synapse Medicine. With a background in public health and clinical pharmacology, Dr. Goehrs identified a critical need for reliable and easily accessible medication information for both healthcare professionals and patients. This led him to establish Synapse Medicine in 2017, a company dedicated to leveraging artificial intelligence to provide trustworthy drug intelligence, aiming to prevent medication errors, improve prescription accuracy, and enhance patient safety. He is passionate about transforming healthcare through technology and is a recognized voice in the health-tech industry, advocating for data-driven solutions to complex medical challenges.
Clement Goehrs's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Successfully co-founded Synapse Medicine in 2017 and has since led its growth as CEO, establishing it as a leading platform for AI-powered medication intelligence used by thousands of healthcare professionals and major healthcare organizations.
Spearheaded multiple successful funding rounds for Synapse Medicine, including a notable $28 million Series B in 2021, enabling the company to scale its operations, expand its team, and further develop its AI capabilities for global impact.
Pioneered the application of artificial intelligence to create a reliable and up-to-date medication information system, directly contributing to the reduction of medication errors and improving patient outcomes in clinical practice.
Gained recognition as an influential leader in the European health tech scene, often invited to speak at industry conferences and contributing to discussions on the future of digital health and AI in medicine.
Stanford University Graduate School of Business - Year 2016
Institut de santé publique, d'épidémiologie et de développement (ISPED) - Year 2015
Université de Bordeaux - Year 2013
Université Paris-Saclay - Year 2006
Lycée Hoche
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Synapse Medicine is a Medication Intelligence company dedicated to ensuring everyone has access to reliable and up-to-date drug information. Their AI-powered platform helps healthcare professionals make informed decisions about prescriptions, reducing medication errors and improving patient safety. For patients, it offers tools to better understand their treatments and manage their health.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.